04/12 – SOLACI@Medtronic Webinar: Lifetime Management Applied to Clinical Practice

Next Wednesday, April 12, at 8:00 p.m. (Argentina / Brazil time), we will hold a new open event in conjunction with Medtronic on “Lifetime Management Applied to Clinical Practice: Structural valve deterioration,coronary access and redo TAVR”.

The event will be attended by prominent and prominent speakers and panelists.

Date: April 12, 2023 at 8:00 PM (Argentina / Brazil time; UTC-3).

Open and free event! Check the schedule of activities below and register!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Fellow’s Corner – Case 1: Chronic Total Occlusion Treated via Retrograde Approach. A True Challenge

Share your experience. Learn from experts. Grow as an interventionalist. We present the first case of this new edition of The Fellow’s Corner, an academic...

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

The webinar “Ultrasound Pulses + Calcium = Coronary Lithotripsy”, held on March 24, 2026 via the Zoom platform, is now available for viewing on...

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...